跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TALTZ - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TALTZ
Authorized
STANDARD
TALTZ
eli lilly canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
585be1614e54ba94
Company
eli lilly canada inc
Type
Standard
Approval Details
Approval Id
585be1614e54ba94
Drug Approval Canada Name
TALTZ
Product Name
TALTZ
Status
Marketed
Status Date
2023-04-12
Original Market Date
2016-08-11
Din
02455110
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D , Prescription
Ahfs
90:24.20.92
Atc Original
L04AC13 IXEKIZUMAB
Atc Name
l 04 ac 13
Aig Number
0158170001
Company Name
eli lilly canada inc
Company Address
SUITE 900, Exchange Tower, 130 King Street West, Toronto, Ontario, Canada, M5X 1B1
Active Ingredients
IXEKIZUMAB
80 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
585be1614e54ba94
Type
Standard
Back to Health Canada Approvals